sCD30, sCD163, and TARC measured at baseline (before) and after therapy. sCD30 (A), sCD163 (B), and TARC (C) measured by enzyme-linked immunosorbent assay at baseline and after therapy in both chemotherapy arm and chemotherapy with addition of Bv. ns, not significant.